---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-23-014561"
form_type: "8-K"
ticker: "MED"
cik: "0000910329"
company_name: "MEDIFAST INC"
filed_at: "2023-05-01T23:59:59+00:00"
generated_at: "2026-06-16T05:53:39.148285+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Medifast Q1 revenue down 16.4% to $349M; guides Q2 revenue $250-270M, EPS $1.32-1.44

## Summary
- Revenue $349M (-16.4% YoY); net income $40M ($3.67 diluted EPS) vs $41.8M ($3.59) prior year.
- Active earning OPTA VIA coaches 58,700 (-8.1%); revenue per coach $5,945 (-9.0%).
- Gross profit margin 70.6% vs 72.4% due to cost inflation and lower volumes.
- Q2 2023 guidance: revenue $250-270M, diluted EPS $1.32-1.44, effective tax rate 24.5-26.25%.
- Quarterly dividend $1.65/share payable May 9; cash $123.7M, no debt.

## SEC filing metadata
- accession: 0001628280-23-014561
- form_type: 8-K
- ticker: MED
- cik: 0000910329
- company_name: MEDIFAST INC
- filed_at: 2023-05-01T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/910329/000162828023014561/0001628280-23-014561-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/910329/000162828023014561/med-20230501.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-23-014561
- JSON: https://secwatch.observer/filing/0001628280-23-014561.json
- Plain text: https://secwatch.observer/filing/0001628280-23-014561.txt

## Key facts
- Earnings Releases
  MEDIFAST INC reported the first quarter ended March 31, 2023 results: revenue $349.0 million, net income $40.0 million, EPS $3.67 per diluted share.
  - Period: the first quarter ended March 31, 2023
  - Revenue: $349.0 million
  - Net income: $40.0 million
  - EPS: $3.67 per diluted share
  - Result: reported results
  source text: Medifast (NYSE: MED), the global company behind one of the fastest-growing health and wellness communities, OPTA VIA® , today reported results for the first quarter ended March 31, 2023. First Quarter 2023 • Revenue of $349.0 million, with revenue per active earning coach of $5,945 • Independent active earning OPTA VIA Coaches of 58,700 • Net income of $40.0 million • Earnings per diluted share (“EPS”) of $3.67
  evidence_url: https://www.sec.gov/Archives/edgar/data/910329/000162828023014561/0001628280-23-014561-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.